Search Results

Regulation (EU) 2023/1182 of the European Parliament and of the Council of 14 June 2023 on specific rules relating to medicinal products for human use intended to be placed on the market in Northern Ireland and amending Directive 2001/83/EC (Text with EEA relevance)

PE/20/2023/REV/2

OJ L 157, 20.6.2023, p. 1–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 157, 20.6.2023, p. 1–7

Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance)

PE/45/2018/REV/1

OJ L 4, 7.1.2019, p. 43–167 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 4, 7.1.2019, p. 43–167

Latest consolidated version:

28/01/2022

Regulation (EU) 2016/793 of the European Parliament and of the Council of 11 May 2016 to avoid trade diversion into the European Union of certain key medicines (codification)

OJ L 135, 24.5.2016, p. 39–52 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 135, 24.5.2016, p. 39–52

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance

OJ L 158, 27.5.2014, p. 1–76 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

OJ L 158, 27.5.2014, p. 1–76

Latest consolidated version:

05/12/2022

Directive 2009/35/EC of the European Parliament and of the Council of 23 April 2009 on the colouring matters which may be added to medicinal products (recast) (Text with EEA relevance)

OJ L 109, 30.4.2009, p. 10–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
This document has been published in a special edition(s) ( HR)

OJ L 109, 30.4.2009, p. 10–13

Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)

OJ L 324, 10.12.2007, p. 121–137 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
This document has been published in a special edition(s) ( HR)

OJ L 324, 10.12.2007, p. 121–137

Latest consolidated version:

26/07/2019

Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance)

OJ L 378, 27.12.2006, p. 1–19 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, SK, SL, FI, SV)
This document has been published in a special edition(s) ( BG, RO, HR)

OJ L 378, 27.12.2006, p. 1–19

Latest consolidated version:

28/01/2019

Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)

OJ L 136, 30.4.2004, p. 1–33 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) ( CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

OJ L 136, 30.4.2004, p. 1–33

Latest consolidated version:

28/01/2022

Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use

OJ L 311, 28.11.2001, p. 67–128 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) ( CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

OJ L 311, 28.11.2001, p. 67–128

Latest consolidated version:

01/01/2022

Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use

OJ L 121, 1.5.2001, p. 34–44 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
This document has been published in a special edition(s) ( CS, ET, LV, LT, HU, MT, PL, SK, SL, BG, RO, HR)

OJ L 121, 1.5.2001, p. 34–44

Latest consolidated version:

01/01/2022